Every time I hear Leslie say "collecting data", I feel like she's repeating the exact words that she has been told when meeting with large pharma's.
It almost sounds like the large pharma's are telling her, if you can collect enough data we're interested in collaborating even before Phase II results. It could very well be why she is prioritising getting the most out of these trials. It may also be one of the reasons for buying out Kaumaya's research.
DATA,DATA, DATA...
Every time I hear Leslie say "collecting data", I feel like...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.9¢ | 3.8¢ | $134.8K | 3.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 1738258 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 494405 | 4 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
